Nasdaq GlobeNewswire

TeraRecon Debuts Next Generation Northstar(TM) AI Explorer at SIIM18

Del

National Harbor, Maryland - May 31st, 2018, May 31, 2018 (GLOBE NEWSWIRE) -- TeraRecon (www.terarecon.com) today announced that its first-of-kind Northstar(TM) AI Explorer has reached a new milestone that allows physicians to interact with individual measurements, markings, and findings created by AI image processing algorithms. To demonstrate the potential of these AI-assisted workflows, the company is previewing an end-to-end cardiac MR analysis workflow in partnership with EnvoyAI (www.envoyai.com) and Corstem (www.corstem.ai) that provides highly automated results while keeping the physician informed and in control. The new Northstar features are the latest in a rapid progression of technological achievements made as the product evolves from a results viewer to a more powerful and integrated AI interaction and observation portal.

The new Northstar AI Explorer(TM) provides the ability to not only accept or reject certain images and reports created by AI, as Northstar has done previously, but now empowers physicians to fine-tune findings and interrogate the clinical assumptions that underlie the results in AI-generated reports. The system is composed of a web-based user interface that works seamlessly alongside or within the physicians' current PACS, EMR, and enterprise viewing systems.

The Northstar AI Explorer and the EnvoyAI platform together form an application framework upon which any 3rd party algorithm developer can build. "TeraRecon strives to make AI-assisted medical imaging interpretations more accessible to physicians by offering an unprecedented level of transparency into AI functionality along with deep integrations into existing workflows that optimize ease of use and efficiency. By exposing the key clinical assumptions that these AI machines are making and stopping to collect physician feedback before proceeding, we reduce risk while accelerating innovation and clinical adoption", said Jeff Sorenson, President and CEO of TeraRecon.

The cardiac MR analysis workflow prototype is composed of Corstem AI-generated anatomic contours and clinical assumptions being quickly verified or adjusted.  The physician feedback is sent to the Corstem application hosted on the EnvoyAI platform. The workflow then completes the cardiac function and fully quantitative pixel-wise perfusion analyses, marks updated findings in the images, and generates the report. The physician can make further adjustments and send the results to the permanent archive, such as the PACS or VNA.

"The most exciting aspect of the Northstar AI Explorer is that physicians can appreciate the quality of the AI findings", said Pascal Labrecque, Chief Operating Officer of Corstem. Pascal continued, "Our proprietary deep learning algorithm performs cardiac MR contouring with some of the most sophisticated motion correction technology available. The combination of TeraRecon's Northstar AI Explorer and the EnvoyAI platform allows cutting-edge AI technology to really shine."

The trained AI algorithms are not continuously learning from physician feedback in real-time, to ensure that tight version-control and testing regimens are maintained. However, with permission and appropriate data sharing protocols from the healthcare institution, their anonymized image data and physician ground truthing feedback may be shared and used by the algorithm developer to make improved versions.

Northstar was installed at its first beta-release customer site this month, Wake Radiology (www.wakerad.com) in Raleigh, North Carolina. "My expectation is that the Northstar viewer is going to simplify the experience for my radiologists. The output from these AI algorithms are expected to far surpass what we could generate individually on any given day, for specific reports. Volumetric measurements and serial comparisons that could not be done or would take a lot of time to do individually should be automated with AI", said Dr. William Way, Chief Medical Officer of Wake Radiology.  Dr. Way continued, "Having these results readily available and nicely integrated into our PACS and reporting workflows is vastly superior to what we are doing now."

"AI is important to where we are going as a radiology provider, and it is nice to be on the cutting edge", said Matt Dewey, Chief Information Officer of Wake Radiology.  Matt continued, "Because algorithms work differently and each of them has different inputs and outputs, my radiologists would otherwise have to have a different way of working with each one.  Northstar solves this problem by providing a simple and consistent way that our physicians work with the output of algorithms from many sources, and adapting itself to their personal preferences."

TeraRecon AI solutions will be demonstrated during the Society for Imaging Informatics in Medicine annual meeting, May 31st through June 2nd in National Harbor, Maryland at Booth #405. Online demonstrations and more information are available by contacting TeraRecon at info@terarecon.com.

About TeraRecon (www.terarecon.com) TeraRecon is a leader in advanced visualization, image viewing, and post-processing. Our flagship product, iNtuition, consistently leads the advanced visualization category of the industry's leading independent technology analyst. We are committed to redefining advanced visualization by leveraging artificial intelligence, and to improving radiology workflow through personalized automation features that increase efficiency.

About EnvoyAI (www.envoyai.com) EnvoyAI facilitates the streamlined distribution and hospital implementation of trained machine learning algorithms via a vendor-neutral distribution platform. EnvoyAI provides a developer platform, integrations, and an open API for algorithm developers, technology partners, and end users. EnvoyAI assists research institutions and emerging AI companies in the translation and commercialization processes, starting with rapid deployment via a scalable, secure, cloud-based infrastructure with the ability to add local components to facilitate on-site deployments as well. EnvoyAI also works with distribution partners to make algorithms on the platform available to a very wide footprint of hospitals and, ultimately, to physicians. 

About Wake Radiology ( www.wakerad.com Founded in 1953, Wake Radiology is the leading provider of outpatient medical imaging in Central North Carolina. Its physicians have been trained as experts in specific imaging specialties - ranging from breast cancer detection and pediatrics to sports medicine and neuroradiology - to accurately diagnose healthcare issues. Another hallmark of Wake Radiology is its commitment to low-dose imaging and the elimination of unnecessary or duplicate exams. This approach strives to improve patient outcomes and reduces the overall cost of healthcare. Wake Radiology is the region's largest outpatient imaging practice with nearly 50 radiologists who perform close to 600,000 procedures each year. It is the first outpatient imaging provider in the Triangle to earn the American College of Radiology's prestigious Breast Imaging Center of Excellence designation. Wake Radiology is an independent, locally owned and physician-led practice that actively supports the local community.

About CorStem (www.corstem.ai) Corstem is a machine learning and artificial intelligence software developer specialized in medical imaging analysis and computer vision. Founded in 2016, its AI-powered tools are setting the standard in dynamic cardiac analysis. Corstem enables a whole new level of efficiency and automation for diagnosis aid to save valuable physician and patient time. 

IMPORTANT REGULATORY NOTICE: The TeraRecon Northstar and Corstem cardiac MR products mentioned herein are not for clinical use or sale at this time.

Press Inquiries US: 1-650-372-1100 | info@terarecon.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: TeraRecon, Inc via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Brookfield Completes Acquisition of Forest City Realty Trust7.12.2018 19:24Pressemelding

NEW YORK and CLEVELAND, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Brookfield Asset Management Inc. (“Brookfield”) (NYSE: BAM) (TSX: BAM.A) (Euronext: BAMA) and Forest City Realty Trust, Inc. (“Forest City”) (NYSE: FCEA) today announced the completion of the acquisition of Forest City by a Brookfield real estate investment fund. The transaction was approved at a special meeting of Forest City’s stockholders held on November 15, 2018. Forest City’s diversified real estate portfolio is comprised of a number of iconic assets across major gateway U.S. cities. The portfolio, which features many natural synergies with Brookfield’s existing real estate operating business, includes 6.3 million square feet of high-quality office space, 2.3 million square feet of premier life sciences assets, 2.2 million square feet of retail space and 18,500 multifamily units. In addition, the portfolio features five large-scale development projects in the New York Metro area, San Francisco and Washington, DC. In connec

Oxford Immunotec Announces Regulatory Acceptance of T-Cell Select™ in China7.12.2018 15:00Pressemelding

OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced regulatory acceptance of the T-Cell Select kit by the China Food and Drug Administration (CFDA). The T-Cell Select kit was designed as an immune cell separation reagent kit to simplify workflow, improve throughput, and reduce hands-on time and labor costs in performing the T-SPOT®.TB test. With the T-Cell Select kit, blood samples collected in a single standard blood tube can be stored for up to 54 hours at room temperature before use, further extending the company’s unrivaled simplicity and logistics advantages for customers. For additional information, please visit: http://www.oxfordimmunotec.com/international/products-services/t-cell-select/. About Oxford Immunotec Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and commercializing proprietary assays for im

Colliers International Announces Leadership Change6.12.2018 22:05Pressemelding

Dylan Taylor tapped to lead Colliers Real Estate Services TORONTO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Colliers International Group Inc. (NASDAQ and TSX: CIGI), a global leader in commercial real estate services and investment management, announced today that effective January 1, 2019, Dylan Taylor will become CEO of Colliers Real Estate Services focusing exclusively on the growth, operational effectiveness and client service opportunities in the Company’s rapidly growing real estate services segment. Jay Hennick, Global Chairman and CEO will continue to be responsible for overall strategy and execution across all the Company’s businesses including its recently established platform in investment management. “Dylan Taylor’s appointment to CEO of Colliers Real Estate Services recognizes his success in building our operations over the last nine years. He will continue to be the driving force behind our growth in real estate services globally and perhaps most importantly, delivering exceptio

H&R Block Selects eGain for AI-Powered Customer Engagement6.12.2018 19:30Pressemelding

Tax preparation giant will use eGain Virtual Assistant for on-demand help SUNNYVALE, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) -- eGain (NASDAQ: EGAN), the leading provider of cloud-based customer engagement solutions, today announced that tax preparation giant H&R Block (NYSE: HRB) has selected eGain Solve™ to automate service and sales interactions for taxpayers at scale. The solution will be used to power H&R Block’s new Ask a Tax Pro service, which was announced today. According to a 2018 Accenture global survey, 70 percent of taxpayers said they would use AI to improve the accuracy of tax filings. In the same survey, 40 percent of respondents reported making a filing error in the last 24 months. As the market leader in tax preparation services, H&R Block wanted to provide high-quality DIY and advisor-assisted experiences at scale using AI, Machine Learning and Virtual Assistance. H&R Block selected eGain based on the company’s connected and rich solution capabilities, domain expertis

Constellation Brands to Invest $100 Million in Women-Led Start-Ups by 20286.12.2018 15:00Pressemelding

Focus on Female Founders Program Provides Resources to Help Women Entrepreneurs Address Untapped Growth Opportunities in the Beverage Alcohol Space and Adjacent Categories VICTOR, N.Y., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, announced today that Constellation Brands Ventures (CBV), the company’s corporate venture capital group, intends to invest $100 million in female-founded or female-led businesses in the beverage alcohol space and adjacent categories by 2028 through a new program, Focus on Female Founders. The company has completed its first investments in two specialty beverage companies: Austin Cocktails and Vivify Beverages. “Our Focus on Female Founders program reinforces our commitment to supporting the advancement of women within our company, within our industry, and in our local communities,” said Mallika Monteiro, chief growth officer, Constellation Brands. “This program is designed to make mean

Seclore Increases the Security of Emails & Attachments with Advanced Automation Capability6.12.2018 15:00Pressemelding

Seclore Email Auto-Protector attaches persistent, encryption and usage controls to sensitive emails without end user involvement MILPITAS, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Seclore, providers of the first open Data-Centric Security Platform, today announced the expansion of their Seclore Email Protector. The new Email Auto-Protector automatically attaches persistent, granular usage controls to sensitive emails and attachments based on predefined rules. The solution offers two key ways to automate email protection. Rules can be defined in the Seclore Email Auto-Protector to automatically apply usage controls to both outgoing and incoming emails and attachments that are sensitive Seclore Email Auto-Protector automatically applies the appropriate usage controls to emails and attachments by leveraging rules defined in other Enterprise Systems such as DLP, Data Classification and Enterprise Applications. “One of the biggest challenges with Encryption and Rights Management technologi

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom